Plasma Exchange and Its Development in the Treatment of Familial Hypercholesterolemia
暂无分享,去创建一个
[1] M. Mancini,et al. Increased Fibrinogen Binding to Platelets from Patients with Familial Hypercholesterolemia , 1986, Arteriosclerosis.
[2] T. Demant,et al. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture. , 1985, Atherosclerosis.
[3] N. Scarpato,et al. Improved reactive hyperemia test after plasma exchange in familial hypercholesterolemia. , 1985, Atherosclerosis.
[4] S. Yokoyama,et al. Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. , 1984, Arteriosclerosis.
[5] S. Grundy,et al. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Armstrong,et al. Selective Continuous Extracorporeal Elimination of Low-Density Lipoproteins from Plasma by Heparin Precipitation without Cations , 1983 .
[7] M. Aviram,et al. Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia. , 1983, Clinical science.
[8] B. Joffe,et al. Treatment of homozygous familial hypercholesterolaemia with probucol. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[9] M. Forman,et al. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. , 1982, Atherosclerosis.
[10] W. Stoffel,et al. APPLICATION OF SPECIFIC EXTRACORPOREAL REMOVAL OF LOW DENSITY LIPOPROTEIN IN FAMILIAL HYPERCHOLESTEROLAEMIA , 1981, The Lancet.
[11] G. Thompson. PLASMA EXCHANGE FOR HYPERCHOLESTEROLAEMIA , 1981, The Lancet.
[12] G. Schonfeld,et al. Successful plasmapheresis in a 4-year-old child with homozygous familial hypercholesterolemia. , 1980, The Journal of pediatrics.
[13] H. Moor,et al. Myelin and glial membrane structures in the optic nerve of normal and jimpy mouse. A freeze-etching study. , 1980, Journal of neuropathology and experimental neurology.
[14] A. Endo,et al. Therapeutic effects of ML-236B in primary hypercholesterolemia. , 1980, Atherosclerosis.
[15] G. Thompson,et al. Reduction of blood viscosity following plasma exchange. , 1979, Atherosclerosis.
[16] S. Moorjani,et al. A NEW APPROACH TO THE MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLÆMIA: REMOVAL OF PLASMA-CHOLESTEROL BASED ON THE PRINCIPLE OF AFFINITY CHROMATOGRAPHY , 1976, The Lancet.
[17] G. Thompson,et al. PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA , 1975, The Lancet.
[18] M. Mancini,et al. Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form. , 1971, Atherosclerosis.
[19] N. Scarpato,et al. Modified Ultrastructural Features, After Plasma-Exchange, of Circulating Platelets from Hypercholesterolemic (Type IIa) Patients: Freeze-Etching and Ultra-Thin Section Study , 1984 .
[20] G. Dagenais,et al. Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC). , 1982, Artery.
[21] W. Stoffel,et al. Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Glueck,et al. Homozygous Hypercholesterolemia; Treatment by Portacaval Shunt , 1980 .
[23] T. Miettinen. Comparison of Cholestyramine, Ileal By-Pass and Portacaval Shunt in the Treatment of Familial Hypercholesterolemia , 1980 .
[24] M. Simons,et al. Letter: Levamisole and lymphocyte responsiveness. , 1975, Lancet.